These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk. Rougeron V; Sam IC; Caron M; Nkoghe D; Leroy E; Roques P J Clin Virol; 2015 Mar; 64():144-52. PubMed ID: 25453326 [TBL] [Abstract][Full Text] [Related]
4. Chikungunya fever: a threat to global public health. Moizéis RNC; Fernandes TAAM; Guedes PMDM; Pereira HWB; Lanza DCF; Azevedo JWV; Galvão JMA; Fernandes JV Pathog Glob Health; 2018 Jun; 112(4):182-194. PubMed ID: 29806537 [TBL] [Abstract][Full Text] [Related]
5. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design. Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S mBio; 2017 Feb; 8(1):. PubMed ID: 28223458 [TBL] [Abstract][Full Text] [Related]
6. Chikungunya virus: host pathogen interaction. Singh SK; Unni SK Rev Med Virol; 2011 Mar; 21(2):78-88. PubMed ID: 21412934 [TBL] [Abstract][Full Text] [Related]
7. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Staples JE; Breiman RF; Powers AM Clin Infect Dis; 2009 Sep; 49(6):942-8. PubMed ID: 19663604 [TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review. Lo Presti A; Cella E; Angeletti S; Ciccozzi M Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290 [TBL] [Abstract][Full Text] [Related]
9. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology. Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT mBio; 2017 Nov; 8(6):. PubMed ID: 29138302 [TBL] [Abstract][Full Text] [Related]
10. Global expansion of chikungunya virus: mapping the 64-year history. Wahid B; Ali A; Rafique S; Idrees M Int J Infect Dis; 2017 May; 58():69-76. PubMed ID: 28288924 [TBL] [Abstract][Full Text] [Related]
11. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development. de Lima Cavalcanti TYV; Pereira MR; de Paula SO; Franca RFO Viruses; 2022 May; 14(5):. PubMed ID: 35632709 [TBL] [Abstract][Full Text] [Related]
12. Chikungunya virus infections: time to act, time to treat. Abdelnabi R; Neyts J; Delang L Curr Opin Virol; 2017 Jun; 24():25-30. PubMed ID: 28414993 [TBL] [Abstract][Full Text] [Related]
13. Cellular and Molecular Immune Response to Chikungunya Virus Infection. Tanabe ISB; Tanabe ELL; Santos EC; Martins WV; Araújo IMTC; Cavalcante MCA; Lima ARV; Câmara NOS; Anderson L; Yunusov D; Bassi ÊJ Front Cell Infect Microbiol; 2018; 8():345. PubMed ID: 30364124 [TBL] [Abstract][Full Text] [Related]
14. Reemergence of chikungunya virus. Morrison TE J Virol; 2014 Oct; 88(20):11644-7. PubMed ID: 25078691 [TBL] [Abstract][Full Text] [Related]
15. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation. Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459 [TBL] [Abstract][Full Text] [Related]
16. Chikungunya virus; an emerging arbovirus in Pakistan. Ali I; Dasti JI J Pak Med Assoc; 2018 Feb; 68(2):252-257. PubMed ID: 29479102 [TBL] [Abstract][Full Text] [Related]
17. Recent progress on chikungunya virus research. An W; Ge N; Cao Y; Sun J; Jin X Virol Sin; 2017 Dec; 32(6):441-453. PubMed ID: 29188427 [TBL] [Abstract][Full Text] [Related]
18. Updates on chikungunya epidemiology, clinical disease, and diagnostics. Sam IC; Kümmerer BM; Chan YF; Roques P; Drosten C; AbuBakar S Vector Borne Zoonotic Dis; 2015 Apr; 15(4):223-30. PubMed ID: 25897809 [TBL] [Abstract][Full Text] [Related]
19. Chikungunya: Its History in Africa and Asia and Its Spread to New Regions in 2013-2014. Zeller H; Van Bortel W; Sudre B J Infect Dis; 2016 Dec; 214(suppl 5):S436-S440. PubMed ID: 27920169 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus. Clayton AM J Infect Dis; 2016 Dec; 214(suppl 5):S506-S509. PubMed ID: 27920182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]